Trinity Point Wealth, LLC Gamida Cell Ltd. Transaction History

Trinity Point Wealth, LLC

  • $595 Million
  • Q1 2024

A detailed history of Trinity Point Wealth, LLC transactions in Gamida Cell Ltd. stock. As of the latest transaction made, Trinity Point Wealth, LLC holds 10,000 shares of GMDA stock, worth $300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$300
Previous $4,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023
SELL
$0.73 - $2.37 $7,300 - $23,700
-10,000 Reduced 50.0%
10,000 $19,000
Q4 2022

Feb 07, 2023
BUY
$1.15 - $2.1 $23,000 - $42,000
20,000 New
20,000 $25,000

Others Institutions Holding GMDA

# of Institutions
58
Shares Held
11.4M
Call Options Held
235K
Put Options Held
70.5K
View Full List

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Trinity Point Wealth, LLC Portfolio

Follow Trinity Point Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trinity Point Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trinity Point Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email